Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Methylated Biomarkers Predictive of Endometrial Cancer Risk

NCT06800677 is registered in ClinicalTrials.gov with University of Manchester as lead sponsor.

NCT NCT06800677
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06800677 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Methylated Biomarkers Predictive of Endometrial Cancer Risk
Lead sponsor
University of Manchester
Phase
Observational
Overall status
Active, not recruiting
Start date
July 31, 2024
Completion date
December 31, 2026
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer